BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36451052)

  • 1. In Vitro Evaluation of Nebulized Pharmaceutical Aerosol Delivery to the Lungs Using a New Heated Dryer System (HDS).
    Spence BM; Longest W; Dutta R; Momin MAM; Strickler S; Hindle M
    AAPS PharmSciTech; 2022 Nov; 24(1):10. PubMed ID: 36451052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFD Guided Optimization of Nose-to-Lung Aerosol Delivery in Adults: Effects of Inhalation Waveforms and Synchronized Aerosol Delivery.
    Dutta R; Spence B; Wei X; Dhapare S; Hindle M; Longest PW
    Pharm Res; 2020 Sep; 37(10):199. PubMed ID: 32968848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a High-Flow Nasal Cannula and Pharmaceutical Aerosol Combination Device.
    Spence BM; Longest W; Wei X; Dhapare S; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2019 Aug; 32(4):224-241. PubMed ID: 30855199
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.
    Longest PW; Golshahi L; Behara SR; Tian G; Farkas DR; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):189-201. PubMed ID: 25192072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of High-Flow Nasal Cannula Device, Nebulizer Type, and Placement on Trans-Nasal Aerosol Drug Delivery.
    Li J; Williams L; Fink JB
    Respir Care; 2022 Jan; 67(1):1-8. PubMed ID: 34670859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nebulizer type, delivery interface, and flow rate on aerosol drug delivery to spontaneously breathing pediatric and infant lung models.
    Ari A
    Pediatr Pulmonol; 2019 Nov; 54(11):1735-1741. PubMed ID: 31313534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of aerosol drug delivery with and without high flow nasal cannula in children.
    Alalwan MA; Fink JB; Ari A
    Pediatr Pulmonol; 2019 Dec; 54(12):1968-1973. PubMed ID: 31468741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Same lung deposited dose in dog dosing a fine and coarse aerosol indicates no difference in intranasal filtration.
    Brülls M; Oag S; Karlsson CA; Lamm Bergström E
    Int J Pharm; 2022 Aug; 624():121977. PubMed ID: 35792234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of Aerosol Bronchodilators Delivery Through High-Flow Nasal Cannula in Pediatric Subjects With Respiratory Distress.
    Al-Subu AM; Nguyen VT; AlAli Y; Yngsdal-Krenz RA; Lasarev MR; Eldridge MW; Hagen SA
    Respir Care; 2020 Oct; 65(10):1464-1469. PubMed ID: 31992665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy.
    Golshahi L; Longest PW; Azimi M; Syed A; Hindle M
    Respir Care; 2014 Oct; 59(10):1476-86. PubMed ID: 24917454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease the flow setting to improve trans-nasal pulmonary aerosol delivery via "high-flow nasal cannula" to infants and toddlers.
    Li J; Gong L; Ari A; Fink JB
    Pediatr Pulmonol; 2019 Jun; 54(6):914-921. PubMed ID: 30920155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Efficiency Nose-to-Lung Aerosol Delivery in an Infant: Development of a Validated Computational Fluid Dynamics Method.
    Bass K; Boc S; Hindle M; Dodson K; Longest W
    J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):132-148. PubMed ID: 30556777
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterizing the Effects of Nasal Prong Interfaces on Aerosol Deposition in a Preterm Infant Nasal Model.
    Bass K; Momin MAM; Howe C; Aladwani G; Strickler S; Kolanjiyil AV; Hindle M; DiBlasi RM; Longest W
    AAPS PharmSciTech; 2022 Apr; 23(5):114. PubMed ID: 35441324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.
    Farkas D; Hindle M; Bonasera S; Bass K; Longest W
    J Aerosol Med Pulm Drug Deliv; 2020 Apr; 33(2):83-98. PubMed ID: 31464559
    [No Abstract]   [Full Text] [Related]  

  • 15. Aerosol therapy through high flow nasal cannula in pediatric patients.
    Al-Subu AM; Hagen S; Eldridge M; Boriosi J
    Expert Rev Respir Med; 2017 Dec; 11(12):945-953. PubMed ID: 28994337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Trans-Nasal Aerosol Delivery Device for Efficient Pulmonary Deposition.
    Zeman KL; Balcazar JR; Fuller F; Donn KH; Boucher RC; Bennett WD; Donaldson SH
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):223-229. PubMed ID: 28157412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-efficiency generation and delivery of aerosols through nasal cannula during noninvasive ventilation.
    Longest PW; Walenga RL; Son YJ; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2013 Oct; 26(5):266-79. PubMed ID: 23273243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A narrative review on trans-nasal pulmonary aerosol delivery.
    Li J; Fink JB; MacLoughlin R; Dhand R
    Crit Care; 2020 Aug; 24(1):506. PubMed ID: 32807226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs.
    Longest W; Spence B; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2019 Oct; 32(5):317-339. PubMed ID: 31287369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in Nose-to-Lung Aerosol Delivery.
    Walenga RL; Tian G; Hindle M; Yelverton J; Dodson K; Longest PW
    J Aerosol Sci; 2014 Dec; 78():11-29. PubMed ID: 25308992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.